ZOLTNERS ANDRIS A 4
4 · Adaptive Biotechnologies Corp · Filed Jan 29, 2020
Insider Transaction Report
Form 4
ZOLTNERS ANDRIS A
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-01-28−100,000→ 0 totalExercise: $0.16Exp: 2020-02-24→ Common Stock (100,000 underlying) - Exercise/Conversion
Common Stock
2020-01-28$0.16/sh+100,000$16,000→ 3,966,016 total - Sale
Common Stock
2020-01-28$26.50/sh−345,000$9,142,500→ 3,621,016 total
Footnotes (1)
- [F1]The shares are fully vested and exercisable.